This brief profile on tobacco health warnings in the South-East Asia Region emphasizes the need for health warnings to ensure tobacco control. It also depicts the situation with respect to tobacco health warnings in the Region. It gives an overview of the status of implementation of Article 11 of the WHO framework convention on tobacco control on packaging and labelling of tobacco products and highlights the main hurdles encountered by Member States in this area.
The health situation in Member States of WHO's South-East Asia Region varies within and across countries. The region accounts for around 25% of the world population yet it incurs 30% of the global disease burden. The Health Situation in the South-East Asia Region was first published in 1980 and the present volume is the eleventh in the series. This publication presents the health situation in the Member States, as reflected by epidemiological data, primarily covering the period 2001-2007. It is presented with a regional perspective and, where appropriate, comparisons have been made with other regions of WHO and with world averages. It describes the progress in health development and reflects the impact of health programs, highlighting the need for concerted action to improve the health of the population of the region. Various professionals--policy-makers, authorities, researchers, health personnel and those committed to the advancement of public health in the Region--will find this book a valuable resource.
This publication is the first bi-regional report on tuberculosis control in the South-East Asia and the Western Pacific Regions. It presents data on TB epidemiology and gauges the enormous progress being made by national TB control programmes in both the regions. It presents the overall success with strategies adopted to control TB and highlights the similarities and differences between individual countries.
This publication is the first bi-regional report on tuberculosis control in the South-East Asia and the Western Pacific Regions. It presents data on TB epidemiology and gauges the enormous progress being made by national TB control programmes in both the regions. It presents the overall success with strategies adopted to control TB and highlights the similarities and differences between individual countries.
Snakebites are well-known medical emergencies in many parts of the world especially in rural areas. Agricultural workers and children are most affected. The incidence of snakebite mortality is particularly high in South-East Asia. Rational use of snake anti-venom can substantially reduce mortality and morbidity due to snake bites. These guidelines are a revised and updated version of those published in 2011. The geographical coverage extends from India in the west to DPR Korea and Indonesia in the east Nepal and Bhutan in the north and to Sri Lanka and Indonesia in the south and south-east. Snakes inhabiting the Indonesian islands east of Wallace?s line (West Papua and Maluku Islands) are part of the Australasian elapid fauna differing from those west of this line. This publication aims to pass on a digest of available knowledge about all clinical aspects of snake-bite to medically trained personnel including medical doctors nurses dispensers and community health workers. They aim to provide suffcient practical information to allow medically trained personnel to assess and treat patients with snake-bites at different levels of the health service.
In view of heavy burden of malaria and prevalence of drug resistant falciparum malaria in the South-East Asia Region these two parallel guidelines one for small hospitals and another one for large hospitals were developed for use by medical personnel who treat severe malaria patients referred from lower-level health facilities. These guidelines were developed by the WHO Regional Office for South-East Asia and the WHO Collaborating Centre for the Clinical Management of Malaria Faculty of Tropical Medicine Mahidol University Thailand. They are based on a review of current evidence existing WHO guidelines and experience in the management of malaria in the Region.
In view of heavy burden of malaria and prevalence of drug resistant falciparum malaria in the South-East Asia Region these two parallel guidelines one for small hospitals and another one for large hospitals were developed for use by medical personnel who treat severe malaria patients referred from lower-level health facilities. These guidelines were developed by the WHO Regional Office for South-East Asia and the WHO Collaborating Centre for the Clinical Management of Malaria Faculty of Tropical Medicine Mahidol University Thailand. They are based on a review of current evidence existing WHO guidelines and experience in the management of malaria in the Region.
Life expectancy is increasing in many parts of the world and more are also being enabled to live with disabling conditions that once might have been fatal. People who are chronically ill, have serious disabilities, have HIV/AIDS, are mentally ill, or victims of accidents and disasters, or elderly - many will need continuing care and support and these numbers will grow. How best to meet these needs is getting more attention. Such care is not to just look after the sick but to enable those with long term illnesses or disabilities to live their lives as fully as possible. Institutionalization is often not the best way of care and the home where the patient lives with family members and friends nearby is often more appropriate. This report examines the options, highlighting the clear benefits of home-based care whilst being aware of the needs of the carers in the home. The report stresses it is time for health systems to take responsibility for providing caregivers in families and communities with the support they both need, and to bring greater benefit to the patient.
This report presents the recommendations of a WHO Expert Committee commissioned to coordinate activities leading to the adoption of international recommendations to assure the quality safety and efficacy of vaccines blood products and other biological medicines and the establishment of international biological reference standards for these products and related diagnostic devices. The report of particular relevance to manufacturers and national regulatory authorities starts with a discussion of general issues brought to the Committee's attention. The second part of the report contains written specifications that establish international regulatory expectations for the following products; DNA vaccines pertussis (whole cell) vaccine plasma (human) for fractionation rabies vaccine and rotavirus vaccine. The report also provides a risk assessment and defines conditions for the safe production of pandemic strain influenza vaccines. The third part of the report provides information on the status and development of international reference materials for various antibodies antigens blood products and related substances and in vitro diagnostic devices.
WHO's concern is that, despite national and global efforts to control malaria, the disease burden remains high, especially in tropical Africa. The situation is further compounded in emergency situations. It is therefore necessary to review the current vector control strategies and their effectiveness in various operational and eco-epidemiological settings and to identify the challenges for implementation in different health systems. These would serve as a basis for the development of a strategic framework for strengthening malaria vector control implementation. The Roll Back Malaria (RBM) Initiative was launched by the WHO Director-General in 1998 as a Cabinet Project to coordinate global actions against malaria. The RBM goal is to reduce the global malaria burden by half by 2010 as compared to 2000"--Publisher's statement
This report sets out the recommendations of an international group of experts relating to developments in the quality assurance of medicines and specifications for drug substances and dosage forms. It contains guidelines of direct relevance to the UN Prequalification Programme for Priority Essential Medicines and for quality control laboratories, including procedures governing the assessment of pharmaceutical products for procurement by UN agencies and for assessing the acceptability of quality control laboratories. It also includes discussion regarding several monographs for inclusion in the International Pharmacopoeia, relating to antiretrovirals, including fixed-dose combinations, TB medicines and antimalarial and paediatric medicines.
This report was prepared for the Asia-Pacific Regional Forum on Health and Environment held on 6?8 October 2016 in Manila Philippines. The report presents the state of the environment and health in the 14 countries of the Regional Forum based on country profiles and United Nations and World Health Organization statistics. This updated version incorporates inputs from Member States at the Regional Forum. The report provides a snapshot of progress among these countries on relevant Sustainable Development Goals (SDGs): SDG 2 (End hunger achieve food security and improved nutrition and promote sustainable agriculture); SDG 3 (Ensure healthy lives and promote well-being for all at all ages); SDG 6 (Ensure availability and sustainable management of water and sanitation for all); SDG 7 (Ensure access to affordable reliable sustainable and modern energy for all); SDG 11 (Make cities and human settlements inclusive safe resilient and sustainable); and SDG 13 (Take urgent action to combat climate change and its impacts).
There is serious concern about the impact of the changing climate. The WHO Regional Office for the Western Pacific has taken the initiative in addressing health issues related to climate change but further action is needed to support efforts to confront climate change in Member States and in various sectors. Health must be mainstreamed into efforts to address climate change and action must be coordinated and integrated across national boundaries and in all sectors. This report synthesizes information and approaches on climate change and health pertinent to Member States in the Western Pacific Region. It also examines efforts and initiatives by various experts and stakeholders with an in-depth look at experiences in seven Member States that reflect the diversity of the Region. Finally it offers recommendations for policy-makers.
This report presents the conclusions of a WHO Expert Committee commissioned to make recommendations on specifications for pesticides used in public health. The aim is to promote the manufacture and use of high quality products that are both acceptable in terms of public health and effective against susceptible vectors of disease. The text includes an outline of the WHO Pesticide Evaluation Scheme (WHOPES) and an overview of recent trends in the various WHO regions.
Early diagnosis and prompt, effective treatment is the basis for the management of malaria and key to reducing malaria mortality and morbidity. An acceptable microscopy service is one that is cost-effective, provides results that are consistently accurate and timely enough to have a direct impact on treatment. This requires a comprehensive and active quality assurance (QA) program. This manual outlines a hierarchical structure based on retraining, validation and the development of competency standards designed to ensure the quality of diagnosis necessary for a successful malaria program, while remaining within the financial and personnel resources likely to be available. The mode of implementation of the QA system outlined in this manual will vary according to the organization of the national laboratory services dealing with malaria, which may fall under the national malaria control program, or under a separate laboratory structure working closely with the malaria program.
Improvements in health cannot be achieved in isolation as they require an integrated, multisectorial development approach. The WHO's Regional Office for the Eastern Mediterranean has introduced the following community-based initiatives: basic development needs approach; healthy villages programme; healthy cities programme; women in health and development. These community-based initiatives have provided a stimulus for health and human development. This training manual provides material to help develop trainers; update the knowledge of field managers; and reinforce leadership and management skills.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.